Intussusception risk rises after rotavirus vax
THE TGA has confirmed an increased risk of intussusception (IS) in children in the week following receipt of rotavirus vaccine.
While the manufacturers of both Rotarix (GSK) and RotaTeq (Merck, CSL) will amend product information to reflect the increased risk, Australia's vaccination program will not change, the TGA said.
"The TGA considers that the overall risk benefit balance of both vaccines remains positive," a report on its website said.
Immediate comment was not available from the vaccine manufacturers.
The TGA said an investigation of 274 cases of IS from three states (NSW, Victoria and